Optinose Inc (OPTN) Directors and Executive Officers - CSIMarket
CSIMarket
 
Optinose Inc   (NASDAQ: OPTN)

Optinose Inc

Officers & Directors


R. JOHN FLETCHER
Chairman of the Board

CATHERINE E. OWEN
Director

KYLE DEMPSEY
Director

WILHELMUS GROENHUYSEN
Director

ANTHONY J. KRICK
Chief Accounting Officer - (Principal Financial Officer and Principal Accounting Officer)

RAMY MAHMOUD
Chief Executive Officer and Director - (Principal Executive Officer)

TOMAS J. HEYMAN
Director

SANDRA L. HELTON
Director

ERIC BEDNARSKI
Director ,

Optinose Inc currently has 201 employees.

  News about Optinose Inc Key Personnel

Optinose’s Prescription Surge Masks Financial Struggles: Can Strategic Restructuring Turn the Tide,

Article for The CSI MarketOptinose s Balancing Act: Prescription Growth Amid Financial Struggles and Strategic RestructuringIn the realm of pharmaceuticals and biotechnology, companies oftentimes navigate a precarious balance between pursuing ambitious innovations and meeting the stringent expectations of investors and stakeholders. Optinose Inc. (NASDAQ: OPTN), a company deeply entrenched in the treatment of chronic rhinosinusitis, is currently at a crossroads—a promising surge in prescription growth amid ongoing financial woes.Preliminary unaudited figures for the fourth quarter of 2024 have revealed that Optinose s XHANCE product, designed to alleviate chronic nasal inflammation, has generated net reve...






OPTN Management Effectiveness OPTN Revenue per Employee OPTN Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.